A protein that quietly suppresses tooth growth may hold the key to regrowing teeth in adults, according to a line of research that has moved from mouse models to the doorstep of human clinical trials.

They could be ready by 2030.

Anecdotal reports and a case series suggest that Ozempic and other GLP-1 receptor agonists may in some cases lead to underproduction of saliva and a dry mouth. (Photo: Getty) People have been mouthing ...